Artemis Investment Management LLP Mirati Therapeutics, Inc. Transaction History

Artemis Investment Management LLP

  • $6.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$132.01 - $190.29 $1.02 Million - $1.47 Million
-7,700 Closed
0 $0
Q3 2021

Oct 26, 2021
SELL
$132.13 - $177.45 $109,007 - $146,396
-825 Reduced 9.68%
7,700 $1.36 Million
Q2 2021

Aug 04, 2021
BUY
$144.0 - $179.73 $1.23 Million - $1.53 Million
8,525 New
8,525 $1.38 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email